Le Lézard
Classified in: Health, Science and technology, Covid-19 virus
Subject: MISCELLANEOUS

VitalHub Announces Availability of MCAP Lite - Rapid Assessment for Discharge Readiness (RADR) Solution for Hospitals Globally


TORONTO, April 09, 2020 (GLOBE NEWSWIRE) -- VitalHub Corp. (the "Company" or "VitalHub") (TSXV: VHI) in response to the pandemic and to support hospitals that need to increase capacity, is making available at no cost, access to a lite version of our Making Care Appropriate for Patients (MCAP) solution and associated evidence-based clinical criteria through it's Rapid Assessment for Discharge Readiness (RADR) solution.

RADR is a derivative of MCAP, the #1 ranked patient flow solution based on combined quality and value scores in the NHS England's Clinical Utilisation Review framework.

MCAP is an internationally validated solution that's been used in North America, Europe, Australia and the Middle East, including at more than >160 hospitals in the UK to identify patient flow improvement opportunities.

The RADR solution is being provided to assist hospitals with discharge planning, recognizing the need for health systems to prepare for and make available capacity to support an influx of patients with severe coronavirus illness. RADR will allow for the rapid identification of large numbers of patients that can be discharged safely and identify barriers that need to be removed to expedite the discharge planning process.

The RADR solution provides a standardized approach to identifying patients that are medically ready to be discharged or transferred from acute care. Standardizing the approach is critically important to maintaining consistency in decision making and will maximize the number of beds that can be freed up while also safeguarding patient health.

RADR is applicable to hospitals globally and fully supports the guidance provided by the NHS in the COVID-19 Hospital Discharge Service Requirements, published March 19, 2020 (https://www.england.nhs.uk/coronavirus/publication/covid-19-hospital-discharge-service-requirements/) which sets out the hospital discharge service requirement for all providers of acute care services ? specifically that: "acute and community hospitals must discharge all patients as soon as they are clinically safe to do so."

RADR is hosted by VitalHub and accessible through any internet-enabled device (desktops, tablets, smartphones, etc.). No personal health information is requested or stored, fully supporting privacy legislation globally. RADR allows for user self registration and is designed to be very easy to use.

"The pandemic has put an extreme burden on hospitals worldwide. We are proud to offer a solution that can assist hospitals to safely discharge patients who can be treated elsewhere including at home. RADR provides a standardized assessment using evidence-based criteria that will enable hospitals to optimize capacity in response to the actual and anticipated surge," said David Maltz, Chief Medical Officer of VitalHub.  

ABOUT VITALHUB CORP.

VitalHub develops mission-critical technology solutions for Health and Human Services providers in the Mental Health (Child through Adult), Long Term Care, Community Health Service, Home Health, Social Service and Acute Care sectors. VitalHub technologies include Blockchain, Mobile, Patient Flow, Web-Based Assessment and Electronic Health Record solutions.
The Company has a robust two-pronged growth strategy, targeting organic growth opportunities within its product suite, and pursuing an aggressive M&A plan. Currently, VitalHub serves 200+ clients across North America. VitalHub is based in Toronto, Canada, with an offshore development hub in Sri Lanka. The Company is publicly traded on the TSX Venture Exchange under the symbol "VHI".

FORWARD-LOOKING STATEMENTS

Certain statements contained in this news release may constitute "forward-looking information" or "financial outlook" within the meaning of applicable securities laws that involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by such forward-looking information or financial outlook. Often, but not always, forward-looking statements can be identified by the use of words such as "plans", "is expected", "expects", "scheduled", "intends", "contemplates", "anticipates", "believes", "proposes" or variations (including negative variations) of such words and phrases, or state that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved. Such statements are based on the current expectations of the management of each entity and are based on assumptions and subject to risks and uncertainties. Although the management of each entity believes that the assumptions underlying these statements are reasonable, they may prove to be incorrect. Although the Corporation has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results to differ from those anticipated, estimated or intended. No forward-looking statement can be guaranteed. Except as required by applicable securities laws, forward-looking statements speak only as of the date on which they are made and the Corporation undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise.

CONTACT INFORMATION

Dan Matlow
Chief Executive Officer, Director
(416) 727-9061
[email protected]


These press releases may also interest you

at 03:00
Todd Britten, DMD, a board-certified periodontist and dental implant specialist in...

at 03:00
SK chemicals (CEO Ahn Jae-hyun), Dongsung Chemical (Co-CEOs Baek Jin-woo and Lee Man-woo), and BYN Black Yak (Chairman Kang Tae-sun, hereinafter Black Yak) announced on the 18th that they've developed sustainable footwear materials using the...

at 02:55
First quarter  Sales of SEK 841 (854) million, a flat growth in local currencies and a decrease of 2% in SEK.Sales per region, in local currencies was +19% in APAC, -2% in EMEA and -14% in Americas.Sales per business area, in local currencies was...

at 02:05
PureTech Health plc ("PureTech" or the "Company") plans to publish its Annual Report and Accounts and financial results for the year ended December 31, 2023, on Thursday, April 25, 2024. A presentation and conference call to discuss the results...

at 02:05
Hansa Biopharma, the pioneer in immunomodulatory enzyme technology for rare IgG mediated diseases, today announced its business update and year-end report for January to March 2024. Highlights for the first quarter of 2024      Strong commercial...

at 01:30
The shares in Aker ASA will be traded ex-dividend NOK 15.50 as from today, 18 April 2024. Investor contact:Fredrik Berge, Head of Investor Relations Aker ASA Tel: +47 450 32 090 E-mail: [email protected] Media contact:Atle Kigen, Head of...



News published on and distributed by: